{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:48:28Z","timestamp":1761630508912},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,1,18]],"date-time":"2009-01-18T00:00:00Z","timestamp":1232236800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1007\/s00105-008-1663-3","type":"journal-article","created":{"date-parts":[[2009,1,16]],"date-time":"2009-01-16T10:55:35Z","timestamp":1232103335000},"page":"116-121","source":"Crossref","is-referenced-by-count":16,"title":["Komorbidit\u00e4ten bei Psoriasis vulgaris"],"prefix":"10.1007","volume":"60","author":[{"given":"W.-H.","family":"Boehncke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Buerger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Boehncke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,1,18]]},"reference":[{"key":"1663_CR1","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1074\/jbc.M309552200","volume":"279","author":"Anderson","year":"2004","unstructured":"Anderson H, Rahmutula D, Gardner D (2004) Tumor necrosis factor-alpha inhibits endothelial nitric-oxide synthase gene promoter activity in bovine aortic endothelial cells. J Biol Chem 279:963\u2013996","journal-title":"J Biol Chem"},{"key":"1663_CR2","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1111\/j.1365-2133.2007.08190.x","volume":"157","author":"Boehncke","year":"2007","unstructured":"Boehncke S, Thaci D, Beschmann H et al (2007) Psoriasis patients show signs of insulin resistance. Br J Dermatol 157:1249\u20131251","journal-title":"Br J Dermatol"},{"key":"1663_CR3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/511051","volume":"80","author":"Cargill","year":"2007","unstructured":"Cargill M, Schrodi SJ, Chang M et al (2007) A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 80:273\u2013390","journal-title":"Am J Hum Genet"},{"key":"1663_CR4","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1468-3083.2004.00863.x","volume":"18","author":"Chodorowska","year":"2004","unstructured":"Chodorowska G, Wojnowska D, Juszkiewicz-Borowiec M (2004) C-reactive protein and alpha2-macroglobulin plasma activity in medium-severe and severe psoriasis. J Eur Acad Dermatol Venereol 18:180\u2013183","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1663_CR5","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.296.14.1735","volume":"296","author":"Gelfand","year":"2006","unstructured":"Gelfand JM, Neimann AL, Shin DB et al (2006) Risk of myocardial infarction in patients with psoriasis. JAMA 296:1735\u20131741","journal-title":"JAMA"},{"key":"1663_CR6","first-page":"1116","volume":"159","author":"Gerdes","year":"2008","unstructured":"Gerdes S, Zahl VA, Knopf H et al (2008) Comedication related to comorbidities: a study in 1203 hospitalized patients with severe psoriasis. Br J Dermatol 159:1116\u20131123","journal-title":"Br J Dermatol"},{"key":"1663_CR7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-2133.2007.07986.x","volume":"157","author":"Gisondi","year":"2007","unstructured":"Gisondi P, Tessari G, Conti A (2007) Prevalence of metabolic sindrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol 157:68\u201373","journal-title":"Br J Dermatol"},{"key":"1663_CR8","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","volume":"52","author":"Hansson","year":"2005","unstructured":"Hansson GI (2005) Inflammation, atherosclerosis and coronary artery disease. N Engl J Med 52:1685\u20131695","journal-title":"N Engl J Med"},{"key":"1663_CR9","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/0190-9622(95)91336-X","volume":"32","author":"Henseler","year":"1995","unstructured":"Henseler T, Christophers E (1995) Disease concomitance in psoriasis. J Am Acad Dermatol 32:982\u2013986","journal-title":"J Am Acad Dermatol"},{"key":"1663_CR10","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","volume":"444","author":"Hotamisligil","year":"2006","unstructured":"Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444:860\u2013867","journal-title":"Nature"},{"key":"1663_CR11","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1161\/01.CIR.0000037521.71373.44","volume":"106","author":"H\u00fcrlimann","year":"2002","unstructured":"H\u00fcrlimann D, Forster A, Noll G et al (2002) Anti-tumor necrosis factor-\u03b1 treatment improves endothelial function in patients with rheumatoid arthritis. Circulation 106:2184\u20132187","journal-title":"Circulation"},{"key":"1663_CR12","first-page":"1213","volume":"32","author":"Jacobsson","year":"2005","unstructured":"Jacobsson LT, Turesson C, G\u00fclfe A et al (2005) Tretmant with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis. J Rheumatol 32:1213\u20131218","journal-title":"J Rheumatol"},{"key":"1663_CR13","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jaad.2008.01.006","volume":"58","author":"Kimball","year":"2008","unstructured":"Kimball AB, Gladman DD, Gelfand JM et al (2008) National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. J Am Acad Dermatol 58:1031\u20131042","journal-title":"J Am Acad Dermatol"},{"key":"1663_CR14","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(08)60725-4","volume":"371","author":"Leonardi","year":"2008","unstructured":"Leonardi CL, Kimball AB, Papp KA et al (2008) Efficacy and safety of ustekinumab, a human interleukin-12\/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomized, double-blind, placebo-controlled trial (PHOENIX 1). Lancet 371:1665\u20131674","journal-title":"Lancet"},{"key":"1663_CR15","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1210\/en.2006-1441","volume":"148","author":"Li","year":"2007","unstructured":"Li G, Barrett EJ, Barrett MO et al (2007) TNF-\u03b1 induces insulin resistance in endothelial cells via a p38 MAPK-dependent pathway. Endocrinology 148:3356\u20133363","journal-title":"Endocrinology"},{"key":"1663_CR16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2133.2006.07562.x","volume":"156","author":"Ludwig","year":"2007","unstructured":"Ludwig RJ, Herzog C, Rostock A et al (2007) Psoriasis: a possible risk factor for development of coronary artery calcification. Br J Dermatol 156:271\u2013276","journal-title":"Br J Dermatol"},{"key":"1663_CR17","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.0022-202X.2004.22318.x","volume":"122","author":"Ludwig","year":"2004","unstructured":"Ludwig RJ, Schultz JE, Boehncke W-H et al (2004) Activated, not resting, platelets increase leukocyte rolling in urine skin utilizing a distinct set of adhesion molecules. J Invest Dermatol 122:830\u2013836","journal-title":"J Invest Dermatol"},{"key":"1663_CR18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1023\/B:EJEP.0000020447.59150.f9","volume":"19","author":"Mallbris","year":"2004","unstructured":"Mallbris L, Akre O, Granath F et al (2004) Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol 19:225\u2013230","journal-title":"Eur J Epidemiol"},{"key":"1663_CR19","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jaad.2005.11.1079","volume":"54","author":"Mallbris","year":"2006","unstructured":"Mallbris L, Granath F, Hamsten A, Stahle M (2006) Psoriasis is associated with lipid abnormalities at the onset of skin disease. J Am Acad Dermatol 54:614\u2013621","journal-title":"J Am Acad Dermatol"},{"key":"1663_CR20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.0022-202X.2005.23681.x","volume":"125","author":"Naldi","year":"2005","unstructured":"Naldi L, Chatenoud L, Linder D et al (2005) Cigarette smoking, body mass index and stressful life events as risk factors for psoriasis: results from an Italian case-control study. J Invest Dermatol 125:61\u201367","journal-title":"J Invest Dermatol"},{"key":"1663_CR21","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jaad.2004.06.017","volume":"52","author":"Prodanovich","year":"2005","unstructured":"Prodanovich S, Ma F, Taylor JR et al (2005) Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis. J Am Acad Dermatol 52:262\u2013267","journal-title":"J Am Acad Dermatol"},{"key":"1663_CR22","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"Taylor","year":"2006","unstructured":"Taylor W, Gladman DD, Helliwell P and the CASPAR Study Group (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54:2665\u20132673","journal-title":"Arthritis Rheum"},{"key":"1663_CR23","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0190-9622(99)70112-X","volume":"41","author":"Rapp","year":"1999","unstructured":"Rapp SR, Feldman SR, Exum ML et al (1999) Psoriasis causes as much disability as other major medical conditions. J Am Acad Dermatol 41:401\u2013407","journal-title":"J Am Acad Dermatol"},{"key":"1663_CR24","doi-asserted-by":"crossref","unstructured":"Ritchlin CT, Kavanaugh A, Gladman DD et al (2008) Treatment recommendations for psoriatic arthritis. Ann Rheum Dis (in press)","DOI":"10.1136\/ard.2008.094946"},{"key":"1663_CR25","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1365-2133.2004.05984.x","volume":"150","author":"Rocha-Pereira","year":"2004","unstructured":"Rocha-Pereira P, Santos-Silva A, Rebelo I et al (2004) The inflammatory response in mild and in severe psoriasis. Br J Dermatol 150:917\u2013928","journal-title":"Br J Dermatol"},{"key":"1663_CR26","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.amjmed.2007.06.020","volume":"120","author":"Setty","year":"2007","unstructured":"Setty AR, Curhan G, Choi HK (2007) Smoking and the risk of psoriasis in women: Nurses Health Study II. Am J Med 120:953\u2013959","journal-title":"Am J Med"},{"key":"1663_CR27","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1001\/archinte.167.15.1670","volume":"167","author":"Setty","year":"2007","unstructured":"Setty AR, Curhan G, Choi HK (2007) Obesity, waist circumference, weight change and the risk of psoriasis in women: Nurses Health Study II. Arch Intern Med 167:1670\u20131675","journal-title":"Arch Intern Med"},{"key":"1663_CR28","first-page":"487","volume":"294","author":"Schmitt","year":"2003","unstructured":"Schmitt D, Carstensen K, Bugdahl R et al (2003) The association of psoriasis vulgaris with internal diseases. Arch Dermatol Res 294:487","journal-title":"Arch Dermatol Res"},{"key":"1663_CR29","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1572-0241.2007.01660.x","volume":"103","author":"Weersma","year":"2008","unstructured":"Weersma RK, Zhernakova A, Nolte IM et al (2008) ATG16L1 and IL23R are associated with inflammatory bowel diseases but not with celiac disease in The Netherlands. Am J Gastroenterol 103:621\u2013627","journal-title":"Am J Gastroenterol"},{"key":"1663_CR30","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1172\/JCI200525102","volume":"115","author":"Wellen","year":"2005","unstructured":"Wellen KE, Hotamisligil GS (2005) Inflammation, stress and diabetes. J Clin Invest 115:1111\u20131119","journal-title":"J Clin Invest"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-008-1663-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-008-1663-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-008-1663-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T19:12:13Z","timestamp":1589483533000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-008-1663-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,18]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["1663"],"URL":"https:\/\/doi.org\/10.1007\/s00105-008-1663-3","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,18]]}}}